Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Congress 2024
  5. Satellite Symposia Webcasts

F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Audience Q&A and panel discussion

Date

16 Sep 2024

Session

F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Topics

Immunotherapy

Tumour Site

Gastrointestinal Cancers

Presenters

Richard Finn, Adam Yopp, Anna Saborowski, Pierce Chow, Manon Allaire

Authors

R.S. Finn1, A. Yopp2, A. Saborowski3, P. Chow4, M. Allaire5

Author affiliations

  • 1 Division Of Hematology/oncology, Geffen School Of Medicine, UCLA - David Geffen School of Medicine, 90095 - Los Angeles/US
  • 2 UT Southwestern Medical Center, 75390-8852 - Dallas/US
  • 3 Gastroenterology, Hepatology And Endocrinology Department, MHH - Medizinische Hochschule Hannover, 30625 - Hannover/DE
  • 4 Division Of Surgery & Surgical Oncology, NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG
  • 5 Hopital Pitié Salpetrière AP-HP, 75013 - Paris/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Richard Finn

Session: F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Resources:

Webcast

Innovating to address unmet needs

Presenter: Richard Finn, Pierce Chow

Session: F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Resources:

Webcast

Current therapeutic approaches in HCC

Presenter: Pierce Chow, Manon Allaire

Session: F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Resources:

Webcast

The importance of surveillance and diagnosis

Presenter: Anna Saborowski, Adam Yopp

Session: F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Resources:

Webcast

Close

Presenter: Richard Finn

Session: F. Hoffmann - La Roche Ltd - Pioneering GI cancer treatments and maximising outcomes for patients with HCC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.